Cargando…

Minimally invasive surgery and cancer: controversies part 1

Perhaps there is no more important issue in the care of surgical patients than the appropriate use of minimally invasive surgery (MIS) for patients with cancer. Important advances in surgical technique have an impact on early perioperative morbidity, length of hospital stay, pain management, and qua...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldfarb, Melanie, Brower, Steven, Schwaitzberg, S. D.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2814196/
https://www.ncbi.nlm.nih.gov/pubmed/19572178
http://dx.doi.org/10.1007/s00464-009-0583-3
_version_ 1782176985767739392
author Goldfarb, Melanie
Brower, Steven
Schwaitzberg, S. D.
author_facet Goldfarb, Melanie
Brower, Steven
Schwaitzberg, S. D.
author_sort Goldfarb, Melanie
collection PubMed
description Perhaps there is no more important issue in the care of surgical patients than the appropriate use of minimally invasive surgery (MIS) for patients with cancer. Important advances in surgical technique have an impact on early perioperative morbidity, length of hospital stay, pain management, and quality of life issues, as clearly proved with MIS. However, for oncology patients, historically, the most important clinical questions have been answered in the context of prospective randomized trials. Important considerations for MIS and cancer have been addressed, such as what are the important immunologic consequences of MIS versus open surgery and what is the role of laparoscopy in the staging of gastrointestinal cancers? This review article discusses many of the key controversies in the minimally invasive treatment of cancer using the pro–con debate format.
format Text
id pubmed-2814196
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-28141962010-02-13 Minimally invasive surgery and cancer: controversies part 1 Goldfarb, Melanie Brower, Steven Schwaitzberg, S. D. Surg Endosc Review Perhaps there is no more important issue in the care of surgical patients than the appropriate use of minimally invasive surgery (MIS) for patients with cancer. Important advances in surgical technique have an impact on early perioperative morbidity, length of hospital stay, pain management, and quality of life issues, as clearly proved with MIS. However, for oncology patients, historically, the most important clinical questions have been answered in the context of prospective randomized trials. Important considerations for MIS and cancer have been addressed, such as what are the important immunologic consequences of MIS versus open surgery and what is the role of laparoscopy in the staging of gastrointestinal cancers? This review article discusses many of the key controversies in the minimally invasive treatment of cancer using the pro–con debate format. Springer-Verlag 2009-07-02 2010 /pmc/articles/PMC2814196/ /pubmed/19572178 http://dx.doi.org/10.1007/s00464-009-0583-3 Text en © The Author(s) 2009 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Review
Goldfarb, Melanie
Brower, Steven
Schwaitzberg, S. D.
Minimally invasive surgery and cancer: controversies part 1
title Minimally invasive surgery and cancer: controversies part 1
title_full Minimally invasive surgery and cancer: controversies part 1
title_fullStr Minimally invasive surgery and cancer: controversies part 1
title_full_unstemmed Minimally invasive surgery and cancer: controversies part 1
title_short Minimally invasive surgery and cancer: controversies part 1
title_sort minimally invasive surgery and cancer: controversies part 1
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2814196/
https://www.ncbi.nlm.nih.gov/pubmed/19572178
http://dx.doi.org/10.1007/s00464-009-0583-3
work_keys_str_mv AT goldfarbmelanie minimallyinvasivesurgeryandcancercontroversiespart1
AT browersteven minimallyinvasivesurgeryandcancercontroversiespart1
AT schwaitzbergsd minimallyinvasivesurgeryandcancercontroversiespart1